Results 101 to 110 of about 6,074,393 (210)

Rab14 regulates the transport of human papillomavirus to the trans‐Golgi network for infectious cell entry

open access: yesFEBS Letters, Volume 600, Issue 19, Page 2917-2928, October 2026.
This study reveals that the small GTPase Rab14 is necessary for human papillomavirus (HPV) infection and plays an essential role in the transport of virions to the trans‐Golgi network (TGN). HPV in the early endosome (EE), which harbors GTP‐bound Rab14, is transported to the TGN through the switch of Rab14 from its GTP‐bound to GDP‐bound form.
Yoshiyuki Ishii, Iwao Kukimoto
wiley   +1 more source

Ebola virus – new threat to global health

open access: yesUniversa Medicina, 2014
Ebola hemorrhagic fever is a fatal infectious disease of humans and primates. The disease is caused by single-stranded RNA viruses belonging to the family Filoviridae.
Rina K. Kusumaratna
doaj   +1 more source

Interim guidance for public health officials on pets of Ebola virus disease contacts [PDF]

open access: yes
This interim guidance document was developed by the AVMA Ebola Companion Animal Response Plan Working Group for local and state animal health and public health officials to facilitate preparation of state response plans.

core  

Ebola Virus disease – an opportunity in crisis? [PDF]

open access: yes, 2015
The recent outbreak of Ebola virus disease (EVD) in West Africa has brought issues of emergency planning and preparedness for emerging viral threats, including Ebola, pandemic influenza and MERS-CoV into focus here in ...
Glyn, Ronan   +3 more
core  

Transport–Reaction–Signal Coupling in Lateral Flow Assays for Next‐Generation Point‐of‐Care Diagnostics

open access: yesAdvanced Science, Volume 13, Issue 58, 19 October 2026.
Lateral flow assays are evolving into interdisciplinary, system‐level sensing platforms. Recent innovations are deconstructed through coupled phases of mass transfer, reaction, and signal transduction, revealing interdependence across porous materials, interfacial chemistry, nanolabels, readout devices, and data‐enabled analysis.
Yan Pan   +6 more
wiley   +1 more source

Ebola virus disease and breastfeeding [PDF]

open access: yesThe Lancet, 2020
Anna E, Thorson   +5 more
openaire   +2 more sources

Resurgence of Ebola in the Democratic Republic of Congo: Lessons Learned and Future Directions

open access: yesHealth Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Introduction The Democratic Republic of the Congo (DRC) remains the global epicenter of Ebola virus disease (EVD), having experienced more than 15 outbreaks since the disease was first identified in 1976. The 2025 resurgence in Kasai Province, caused by Orthoebolavirus zairense, resulted in over 60 confirmed cases and a case fatality rate ...
Majani Edward   +6 more
wiley   +1 more source

Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’

open access: yes
Vox Sanguinis, EarlyView.
Ramune Sepetiene   +6 more
wiley   +1 more source

Cholesterol 25‐Hydroxylase Deficiency Provides an Optimal and Durable Protective T Helper 1 Immunity via Interleukin‐12–Interleukin‐2 Axis in BCG‐Vaccinated Mice

open access: yesMedComm, Volume 7, Issue 10, October 2026.
CH25H deficiency permits optimal dendritic cell activation following BCG exposure, characterized by increased IL‐12p70 production. In vivo, CH25H deficiency promotes enhanced BCG‐mediated protection and sustained IL‐2 producing T cell response. ABSTRACT Bacillus Calmette‐Guérin (BCG) remains the only licensed vaccine for tuberculosis (TB), yet its ...
Hagyu Kim   +6 more
wiley   +1 more source

Post-exposure treatment of Ebola virus using passive immunotherapy: proposal for a new strategy

open access: yesJournal of Venomous Animals and Toxins including Tropical Diseases, 2015
Background Better treatments are urgently needed for the management of Ebola virus epidemics in Equatorial Africa. Methods We conducted a systematic review of the literature on the use of passive immunotherapy for the treatment or prevention of Ebola ...
Jean-Philippe Chippaux   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy